Top Markets
#1 Helium Helium +58.32%
#2 TENDIES TENDIES +41.63%
#3 Seeker Seeker +22.48%
#4 Pons Pons +16.47%
#5 UnifAI Network UnifAI Network +13.40%
#6 Songbird Songbird +12.15%
#7 Lista DAO Lista DAO +10.07%
#8 OSK OSK +9.90%
#9 Audiera Audiera +9.88%
#10 Wrapped STX (Velar) Wrapped STX (Velar) +8.51%
Coin of the day
Helium Helium
設定
言語
日本
通貨
USD
テーマ
SpyGlass Pharma, Inc. Common Stock SpyGlass Pharma, Inc. Common Stock

SpyGlass Pharma, Inc. Common Stock

SGP
株式のランク #10213
SpyGlass Pharma, Inc. is an advanced biopharmaceutical company dedicated to... SpyGlass Pharma, Inc. is an advanced biopharmaceutical company dedicated to developing innovative therapeutic approaches for individuals suffering from chronic eye conditions. Its flagship investigational product, the Bimatoprost Drug Pad-IOL System (BIM-IOL System), is engineered for implantation during standard cataract removal procedures with the aim of reducing elevated intraocular pressure (IOP) in patients afflicted with either open-angle glaucoma (OAG) or ocular hypertension (OHT). Co-founded in January 2019 by Malik Y. Kahook and Glenn Sussman, the company maintains its headquarters in Aliso Viejo, CA.
株価
$26.13
最終同期: 2026-08-28
時価総額
$873.45M
変化（1日）
-2.99%
変化（1年）
-
国
US
取引 SpyGlass Pharma, Inc. Common Stock (SGP)

カテゴリー

Healthcare
SpyGlass Pharma, Inc. Common Stock（SGP）のEPS
2026 時点のEPS TTM: 0
SpyGlass Pharma, Inc. Common Stockの最新の財務報告と株価によると、同社の現在のEPS（TTM）は0です。2026年末には、EPSは0で、2026年のEPS0と同等でした。
SpyGlass Pharma, Inc. Common StockのEPS履歴（2026から2026まで）
各年末時点のEPS
年 EPS 変化
提供された日付のデータは十分ではありません。
同様の企業または競合他社のEPS
企業 EPS EPSの差 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $-5.29 -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $-7.98 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH